Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Valaciclovir
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Valaciclovir 500mg tablets
0503021A0AAAAAA
|
Valaciclovir | Valaciclovir | Infections | 14,569 |
|
Valaciclovir 250mg tablets
0503021A0AAACAC
|
Valaciclovir | Valaciclovir | Infections | 732 |
|
Valtrex 500mg tablets
0503021A0BBAAAA
|
Valtrex | Valaciclovir | Infections | 705 |
|
Valaciclovir 1g tablets
0503021A0AAAHAH
|
Valaciclovir | Valaciclovir | Infections | 237 |
|
Valtrex 250mg tablets
0503021A0BBABAC
|
Valtrex | Valaciclovir | Infections | 13 |
|
Valaciclovir 200mg/5ml oral suspension
0503021A0AAAGAG
|
Valaciclovir | Valaciclovir | Infections | 3 |
|
Valaciclovir 100mg/5ml oral suspension
0503021A0AAAEAE
|
Valaciclovir | Valaciclovir | Infections | No data available |
|
Valaciclovir 250mg/5ml oral suspension
0503021A0AAAFAF
|
Valaciclovir | Valaciclovir | Infections | No data available |
|
Valaciclovir 25mg/1ml oral suspension
0503021A0AAADAD
|
Valaciclovir | Valaciclovir | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.